This SHINE Cassiopeia Facility produces the aseptic Active Pharmaceutical Ingredient, and it is the largest radio isotope Lutetium-177 commercial-scale production facility in North America. Lutetium-177 is a key component for targeted radiopharmaceutical treatments for neuroendocrine tumors and late-stage prostate cancer. This single-story 18,900 square feet includes ISO 7 & ISO 8 and Grade C and D cleanroom production lines, material and personnel airlocks, a quality control lab, and decay storage. The cleanrooms include hot cells where the production of the Lutetium-177 occurs in a lead-shielded containment with robotic manipulators. These renovations and additions greatly improved the look and function to the space.

‍